Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Topchiy, Elena ^a   Cirstea, Mihai ^a   Kong, HyeJin Julia ^a   Boyd, John H ^a   Wang, Yingjin ^a   Russell, James A ^a   Walley, Keith R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KEXIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; SMALL INTERFERING RNA; SUBTILISIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN RECEPTOR; PCSK9 PROTEIN, MOUSE; PROPROTEIN CONVERTASE 9;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUSE OF DEATH; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DOWN REGULATION; HUMAN; HUMAN CELL; INTERNALIZATION; LIVER CELL; LIVER DYSFUNCTION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEPSIS; SEPTIC SHOCK; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; HEP-G2 CELL LINE; LIVER; METABOLISM; REPRODUCIBILITY; TIME FACTOR;

ANIMALS; HEP G2 CELLS; HEPATOCYTES; HUMANS; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; PROPROTEIN CONVERTASE 9; RECEPTORS, LDL; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 84969767006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155030     Document Type: Article

References (43)

1. Russell JA. Management of sepsis. The New England journal of medicine. 2006; 355(16):1699-713. PMID: 17050894.
2. Azzam KM, Fessler MB. Crosstalk between reverse cholesterol transport and innate immunity. Trends in endocrinology and metabolism: TEM. 2012; 23(4):169-78. Epub 2012/03/13. doi: 10.1016/j.tem.2012.02.001 PMID: 22406271; PubMed Central PMCID: PMC3338129.
3. Walley KR, Thain KR, Russell JA, Reilly MP, Meyer NJ, Ferguson JF, et al. PCSK9 is a critical regulator of the innate immune response and septic shock outcome. Science translational medicine. 2014; 6 (258):258ra143. Epub 2014/10/17. doi: 10.1126/scitranslmed.3008782 PMID: 25320235.
4. Maxwell KN, Breslow JL. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(18):7100-5. Epub 2004/05/01. doi: 10.1073/pnas.0402133101 PMID: 15118091; PubMed Central PMCID: PMC406472.
5. Lagace TA, Curtis DE, Garuti R, McNutt MC, Park SW, Prather HB, et al. Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice. The Journal of clinical investigation. 2006; 116(11):2995-3005. Epub 2006/11/03. doi: 10.1172/JCI29383 PMID: 17080197; PubMed Central PMCID: PMC1626117.
6. Walley KR, Francis GA, Opal SM, Stein EA, Russell JA, Boyd JH. The Central Role of PCSK9 in Septic Pathogen Lipid Transport and Clearance. American journal of respiratory and critical care medicine. 2015. Epub 2015/08/08. doi: 10.1164/rccm.201505-0876CI PMID: 26252194.
7. Levels JH, Marquart JA, Abraham PR, van den Ende AE, Molhuizen HO, van Deventer SJ, et al. Lipopolysaccharide is transferred from high-density to low-density lipoproteins by lipopolysaccharide-binding protein and phospholipid transfer protein. Infection and immunity. 2005; 73(4):2321-6. Epub 2005/ 03/24. doi: 10.1128/IAI.73.4.2321-2326.2005 PMID: 15784577; PubMed Central PMCID: PMC1087464.
8. Scott MJ, Liu S, Shapiro RA, Vodovotz Y, Billiar TR. Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism. Hepatology. 2009; 49(5):1695-708. Epub 2009/03/20. doi: 10.1002/hep.22839 PMID: 19296467; PubMed Central PMCID: PMC2677122.
9. Scott MJ, Liu S, Su GL, Vodovotz Y, Billiar TR. Hepatocytes enhance effects of lipopolysaccharide on liver nonparenchymal cells through close cell interactions. Shock. 2005; 23(5):453-8. Epub 2005/04/19. PMID: 15834312.
10. Deng M, Scott MJ, Loughran P, Gibson G, Sodhi C, Watkins S, et al. Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. Journal of immunology. 2013; 190(10):5152-60. Epub 2013/04/09. doi: 10.4049/jimmunol.1300496 PMID: 23562812; PubMed Central PMCID: PMC3644895.
11. Rashid S, Curtis DE, Garuti R, Anderson NN, Bashmakov Y, Ho YK, et al. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(15):5374-9. Epub 2005/04/05. 0501652102 [pii] doi: 10.1073/pnas.0501652102 PMID: 15805190; PubMed Central PMCID: PMC556275.
12. http://www.who.int/mediacentre/factsheets/fs310/en/.
13. Dinh LN, Schildbach MA, Maxwell RS, Siekhaus WJ, Balazs B, McLean W 2nd. H2O outgassing from silica-filled polysiloxane TR55. Journal of colloid and interface science. 2004; 274(1):25-32. Epub 2004/05/04. doi: 10.1016/j.jcis.2003.12.052 PMID: 15120274.
14. Choi S, Korstanje R. Proprotein convertases in high-density lipoprotein metabolism. Biomarker research. 2013; 1(1):27. Epub 2013/11/21. doi: 10.1186/2050-7771-1-27 PMID: 24252756; PubMed Central PMCID: PMC4177610.
15. Degrace P, Moindrot B, Mohamed I, Gresti J, Du ZY, Chardigny JM, et al. Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid. Journal of lipid research. 2006; 47(12):2647-55. Epub 2006/09/08. doi: 10.1194/jlr.M600140-JLR200 PMID: 16957181.
16. Mimura Y, Sakisaka S, Harada M, Sata M, Tanikawa K. Role of hepatocytes in direct clearance of lipopolysaccharide in rats. Gastroenterology. 1995; 109(6):1969-76. Epub 1995/12/01. PMID: 7498663.
17. Treon SP, Thomas P, Broitman SA. Lipopolysaccharide (LPS) processing by Kupffer cells releases a modified LPS with increased hepatocyte binding and decreased tumor necrosis factor-alpha stimulatory capacity. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. 1993; 202(2):153-8. Epub 1993/02/01. PMID: 8424104.
18. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990; 249(4975):1431-3. Epub 1990/09/21. PMID: 1698311.
19. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical care medicine. 1992; 20(6):864-74. Epub 1992/06/01. PMID: 1597042.
20. Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, et al. Search for associated higgs boson production WH→WWW∗→l+/-nul'+/-nu'+X in pp collisions at square root s = 1.96 Te V. Physical review letters. 2006; 97(15):151804. Epub 2006/12/13. PMID: 17155320.
21. van Oosten M, van de Bilt E, van Berkel TJ, Kuiper J. New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infection and immunity. 1998; 66 (11):5107-12. Epub 1998/10/24. PMID: 9784510; PubMed Central PMCID: PMC108636.
22. Li XY, Zhang C, Wang H, Ji YL, Wang SF, Zhao L, et al. Tumor necrosis factor alpha partially contributes to lipopolysaccharide-induced downregulation of CYP3A in fetal liver: its repression by a low dose LPS pretreatment. Toxicology letters. 2008; 179(2):71-7. Epub 2008/05/27. doi: 10.1016/j.toxlet.2008.04.005 PMID: 18501536.
23. Liu S, Salyapongse AN, Geller DA, Vodovotz Y, Billiar TR. Hepatocyte toll-like receptor 2 expression in vivo and in vitro: role of cytokines in induction of rat TLR2 gene expression by lipopolysaccharide. Shock. 2000; 14(3):361-5. PMID: 11028557
24. Gautier T, Lagrost L. Plasma PLTP (phospholipid-transfer protein): an emerging role in 'reverse lipopolysaccharide transport' and innate immunity. Biochemical Society transactions. 2011; 39(4):984-8. Epub 2011/07/27. doi: 10.1042/BST0390984 PMID: 21787334.
25. Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. Journal of lipid research. 2004; 45(7):1169-96. PMID: 15102878
26. Levels JH, Abraham PR, van Barreveld EP, Meijers JC, van Deventer SJ. Distribution and kinetics of lipoprotein-bound lipoteichoic acid. Infection and immunity. 2003; 71(6):3280-4. Epub 2003/05/23. PMID: 12761109; PubMed Central PMCID: PMC155762.
27. Victorov AV, Medvedeva NV, Gladkaya EM, Morozkin AD, Podrez EA, Kosykh VA, et al. Composition and structure of lipopolysaccharide-human plasma low density lipoprotein complex. Analytical ultracentrifugation,31P-NMR, ESR and fluorescence spectroscopy studies. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1989; 984(1):119-27. doi: 10.1016/0005-2736(89)90351-9
28. Murch O, Collin M, Hinds CJ, Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive care medicine. 2007; 33(1):13-24. Epub 2006/11/10. doi: 10.1007/s00134-006-0432-y PMID: 17093985.
29. Vreugdenhil AC, Rousseau CH, Hartung T, Greve JW, van 't Veer C, Buurman WA. Lipopolysaccharide (LPS)-binding protein mediates LPS detoxification by chylomicrons. Journal of immunology. 2003; 170 (3):1399-405. Epub 2003/01/23. PMID: 12538700.
30. Liao W, Rudling M, Angelin B. Endotoxin suppresses mouse hepatic low-density lipoprotein-receptor expression via a pathway independent of the toll-like receptor 4. Hepatology. 1999; 30(5):1252-6. Epub 1999/10/26. doi: 10.1002/hep.510300524 PMID: 10534347.
31. van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP. Lipoprotein metabolism in patients with severe sepsis. Critical care medicine. 2003; 31(5):1359-66. PMID: 12771603
32. Bray N. Sepsis: PCSK9 blockade helps clear pathogenic lipids. Nat Rev Drug Discov. 2014; 13 (12):886-7. doi: 10.1038/nrd4492
33. Maxwell KN, Fisher EA, Breslow JL. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(6):2069-74. Epub 2005/01/29. doi: 10.1073/pnas.0409736102 PMID: 15677715; PubMed Central PMCID: PMC546019.
34. Liao W, Rudling M, Angelin B. Endotoxin suppresses rat hepatic low-density lipoprotein receptor expression. Biochem J. 1996; 313(Pt 3):873-8. PMID: 8611169
35. Li XY, Zhang C, Wang SF, Ji YL, Wang H, Zhao L, et al. Maternally administered lipopolysaccharide (LPS) upregulates the expression of heme oxygenase-1 in fetal liver: the role of reactive oxygen species. Toxicology letters. 2008; 176(3):169-77. Epub 2008/02/05. doi: 10.1016/j.toxlet.2007.10.010 PMID: 18242889.
36. Laugerette F, Furet JP, Debard C, Daira P, Loizon E, Geloen A, et al. Oil composition of high-fat diet affects metabolic inflammation differently in connection with endotoxin receptors in mice. American journal of physiology Endocrinology and metabolism. 2012; 302(3):E374-86. Epub 2011/11/19. doi: 10.1152/ajpendo.00314.2011 PMID: 22094473.
37. Clark RW, Cunningham D, Cong Y, Subashi TA, Tkalcevic GT, Lloyd DB, et al. Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection. Journal of lipid research. 2010; 51(5):967-74. Epub 2009/12/08. doi: 10.1194/jlr.M002295 PMID: 19965592; PubMed Central PMCID: PMC2853464.
38. Poirier S, Mayer G, Benjannet S, Bergeron E, Marcinkiewicz J, Nassoury N, et al. The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2. The Journal of biological chemistry. 2008; 283(4):2363-72. Epub 2007/11/28. M708098200 [pii] doi: 10.1074/jbc.M708098200 PMID: 18039658.
39. Roubtsova A, Munkonda MN, Awan Z, Marcinkiewicz J, Chamberland A, Lazure C, et al. Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue. Arterioscler Thromb Vasc Biol. 2011; 31(4):785-91. doi: 10.1161/ATVBAHA.110.220988 PMID: 21273557
40. Tiebel O, Oka K, Robinson K, Sullivan M, Martinez J, Nakamuta M, et al. Mouse very low-density lipoprotein receptor (VLDLR): gene structure, tissue-specific expression and dietary and developmental regulation. Atherosclerosis. 1999; 145(2):239-51. PMID: 10488949
41. Abaza R, Rashid MG, Sferra JJ. Obstructive uropathy from giant inguinal bladder and ureteral herniation. Journal of the American College of Surgeons. 2005; 201(2):314. Epub 2005/07/26. doi: 10.1016/j.jamcollsurg.2004.12.026 PMID: 16038829.
42. Abazov VM, Abbott B, Abolins M, Acharya BS, Adams M, Adams T, et al. Measurement of the Bs(0) lifetime using semileptonic decays. Physical review letters. 2006; 97(24):241801. Epub 2007/02/07. PMID: 17280267.
43. Nesseler N, Launey Y, Aninat C, Morel F, Malledant Y, Seguin P. Clinical review: The liver in sepsis. Critical care. 2012; 16(5):235. Epub 2012/11/09. doi: 10.1186/cc11381 PMID: 23134597; PubMed Central PMCID: PMC3682239.